45 CFR § 180 compliance
A · 100
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,558
Insurances with rates
6
CPT / HCPCS codes
4,318
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2326 | Nusinersen (PF) 12 mg/5 mL Soln 5 mL VIAL | $351,752 | $137,183 | $1,123 | $1,769 | 3 |
| J0225 | Vutrisiran 25 mg/0.5 mL Syringe 0.5 mL SYRINGE | $305,915 | $119,307 | $64,242 | $229,436 | 3 |
| 63664 | REVJ INCL RPLCMT NSTIM ELTRD PLT/PDLE INCL FLUOR | $270,510 | $105,499 | $10,002 | $35,720 | 3 |
| Q9982 | Flutemetamol F-18 5 mCi (185 MBq) Soln 1 Each VIAL | $228,141 | $88,975 | $47,910 | $171,106 | 3 |
| Q2043 | Sipuleucel-T in LR 50 million cell/250 mL Susp 250 mL BAG | $180,340 | $70,333 | $55,137 | $86,860 | 3 |
| J0224 | Lumasiran 94.5 mg/0.5 mL Soln 0.5 mL VIAL | $163,157 | $63,631 | $305 | $481 | 3 |
| A9513 | Lutetium Lu 177 Dotatate 10 mCi/mL (370 mBq/mL) Soln 1 Each VIAL | $153,434 | $59,839 | $32,221 | $115,075 | 3 |
| 90288 | Botulism Immune Globulin (Human) 100 mg Recon soln 1 Each VIAL | $137,525 | $53,635 | $28,880 | $103,144 | 3 |
| J7352 | Afamelanotide 16 mg Implant 1 Each VIAL | $136,966 | $53,417 | $3,220 | $5,073 | 3 |
| J9226 | Histrelin 50 mg (65 mcg/day) Kit 1 Each KIT | $130,121 | $50,747 | $42,320 | $66,668 | 3 |
| J1823 | Inebilizumab-cdon 10 mg/mL Soln 10 mL VIAL | $125,765 | $49,048 | $463 | $729 | 3 |
| A9607 | Lutetium Lu-177 Vipivotide tetraxetan 27 mCi/mL (1,000 MBq/mL) Soln 1 Each VIAL | $122,445 | $47,754 | $25,713 | $91,834 | 3 |
| J0223 | Givosiran 189 mg/mL Soln 1 mL VIAL | $115,695 | $45,121 | $108 | $170 | 3 |
| C9293 | Glucarpidase 1,000 unit Recon soln 1 Each VIAL | $105,551 | $41,165 | $22,166 | $79,163 | 3 |
| J9228 | Ipilimumab 200 mg/40 mL (5 mg/mL) Soln 40 mL VIAL | $92,670 | $36,141 | $164 | $258 | 3 |
| J9269 | Tagraxofusp-erzs 1,000 mcg/mL Soln 1 mL VIAL | $89,074 | $34,739 | $310 | $488 | 3 |
| J0202 | Alemtuzumab 12 mg/1.2 mL Soln 1.2 mL VIAL | $77,973 | $30,409 | $2,195 | $3,458 | 3 |
| A9606 | Radium Ra 223 Dichloride 1,100 kBq/mL(30 microcurie/mL) Soln 1 Each VIAL | $76,973 | $30,019 | $162 | $255 | 3 |
| J2507 | Pegloticase 8 mg/mL Soln 1 mL VIAL | $76,801 | $29,952 | $3,112 | $4,902 | 3 |
| J9118 | Calaspargase pegol-mknl 750 unit/mL Soln 5 mL VIAL | $74,303 | $28,978 | $15,604 | $55,727 | 3 |
| J9359 | Loncastuximab Tesirine-lpyl 10 mg Recon soln 1 Each VIAL | $69,530 | $27,117 | $189 | $297 | 3 |
| J0593 | Lanadelumab-flyo 300 mg/2 mL (150 mg/mL) Soln 2 mL VIAL | $69,460 | $27,090 | $14,587 | $52,095 | 3 |
| J9281 | mitoMYcin 40 mg x 2 Kit 1 Each VIAL | $65,266 | $25,454 | $286 | $450 | 3 |
| J1951 | Leuprolide (Pediatric 6 Month) 45 mg Syringe 1 Each SYRINGE | $65,030 | $25,362 | $133 | $210 | 3 |
| J9348 | Naxitamab-gqgk 4 mg/mL Soln 10 mL VIAL | $63,229 | $24,659 | $557 | $878 | 3 |
| J9600 | Porfimer 75 mg Recon soln 1 Each VIAL | $62,357 | $24,319 | $21,865 | $34,445 | 3 |
| J9229 | Inotuzumab Ozogamicin 0.9 mg (0.25 mg/mL initial) Recon soln 1 Each VIAL | $60,687 | $23,668 | $2,445 | $3,851 | 3 |
| 0620T | ENDOVASCULAR VENOUS ARTERIALIZATION TIBL/PRNL VN | $58,227 | $22,709 | $12,228 | $43,670 | 3 |
| C9774 | REVASC LITHOTR-ATHER TIB/PER | $58,227 | $22,709 | $12,228 | $43,670 | 3 |
| C9773 | REVASC LITHOTR-STENT TIB/PER | $58,227 | $22,709 | $12,228 | $43,670 | 3 |
| C9775 | REVASC LITH-STEN-ATH TIB/PER | $58,227 | $22,709 | $12,228 | $43,670 | 3 |
| J7311 | Fluocinolone 0.59 mg Implant 1 Each PACKET | $54,797 | $21,371 | $333 | $524 | 3 |
| J9274 | Tebentafusp-tebn 100 mcg/0.5 mL Soln 0.5 mL VIAL | $54,074 | $21,089 | $11,355 | $40,555 | 3 |
| J9266 | PEGaspargase 750 unit/mL Soln 5 mL VIAL | $53,617 | $20,911 | $23,564 | $37,122 | 3 |
| J3316 | Triptorelin 22.5 mg Recon susp 1 Each VIAL | $52,435 | $20,450 | $3,064 | $4,827 | 3 |
| 36837 | PERQ AV FISTULA CREATION UXTR SEP ACCESS SITES | $51,533 | $20,098 | $10,822 | $38,650 | 3 |
| 36836 | PERQ AV FISTULA CREATION UXTR SINGLE ACCESS | $51,533 | $20,098 | $10,822 | $38,650 | 3 |
| 33902 | PERQ P-ART REVSC ST 1ST ABNOR CONNJ UNILATERAL | $51,533 | $20,098 | $10,822 | $38,650 | 3 |
| J2350 | Ocrelizumab 30 mg/mL Soln 10 mL VIAL | $51,260 | $19,991 | $60 | $95 | 3 |
| J0638 | Canakinumab (PF) 150 mg/mL Soln 1 mL VIAL | $49,321 | $19,235 | $119 | $187 | 3 |
| A9604 | Samarium Sm 153-Lexidronam 5,550 MBq/3 mL Soln 1 Each VIAL | $46,900 | $18,291 | $4,381 | $6,901 | 3 |
| 33270 | INS/RPLCMNT PERM SUBQ IMPLTBL DFB W/SUBQ ELTRD | $45,721 | $17,831 | $29,219 | $104,352 | 3 |
| J9371 | vinCRIStine Liposomal 5 mg/31 mL(0.16 mg/mL) Final Kit 1 Each KIT | $45,153 | $17,610 | $3,422 | $5,391 | 3 |
| J9309 | Polatuzumab vedotin-piiq 140 mg Recon soln 1 Each VIAL | $44,973 | $17,539 | $118 | $186 | 3 |
| 0627T | PERQ NJX ALGC CELL &/PRDCT UNI/BI FLUOR LMBR 1ST | $44,638 | $17,409 | $9,374 | $33,479 | 3 |
| 0629T | PERQ NJX ALGC CELL&/PRDCT UNI/BI CT LMBR 1ST | $44,638 | $17,409 | $9,374 | $33,479 | 3 |
| J3241 | Teprotumumab-trbw 500 mg Recon soln 1 Each VIAL | $44,563 | $17,380 | $321 | $506 | 3 |
| J2502 | Pasireotide 10 mg Recon susp 1 Each VIAL | $43,743 | $17,060 | $392 | $617 | 3 |
| J9298 | Nivolumab-Relatlimab-rmbw 240-80 mg/20 mL Soln 20 mL VIAL | $39,484 | $15,399 | $8,292 | $29,613 | 3 |
| J1300 | Eculizumab 300 mg/30 mL Soln 30 mL VIAL | $37,577 | $14,655 | $228 | $359 | 3 |
Showing top 50 of 4,558 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.